Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15505054rdf:typepubmed:Citationlld:pubmed
pubmed-article:15505054lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C0009813lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C0079281lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C0035301lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C0031469lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C1720298lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:15505054lifeskim:mentionsumls-concept:C0054222lld:lifeskim
pubmed-article:15505054pubmed:issue11lld:pubmed
pubmed-article:15505054pubmed:dateCreated2004-10-26lld:pubmed
pubmed-article:15505054pubmed:abstractTextTo examine the inhibitory effects of topically instilled bunazosin hydrochloride (bunazosin), a selective alpha1-adrenoceptor antagonist, on the retinal artery constrictions induced by intravitreous phenylephrine hydrochloride (phenylephrine) and endothelin (ET)-1 in rabbits.lld:pubmed
pubmed-article:15505054pubmed:languageenglld:pubmed
pubmed-article:15505054pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:citationSubsetIMlld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15505054pubmed:statusMEDLINElld:pubmed
pubmed-article:15505054pubmed:monthNovlld:pubmed
pubmed-article:15505054pubmed:issn0146-0404lld:pubmed
pubmed-article:15505054pubmed:authorpubmed-author:IchikawaMasak...lld:pubmed
pubmed-article:15505054pubmed:authorpubmed-author:AraieMakotoMlld:pubmed
pubmed-article:15505054pubmed:authorpubmed-author:SummersLinda...lld:pubmed
pubmed-article:15505054pubmed:authorpubmed-author:OkadaYujiYlld:pubmed
pubmed-article:15505054pubmed:authorpubmed-author:IshiiKiyoshiKlld:pubmed
pubmed-article:15505054pubmed:authorpubmed-author:AsaiYukiYlld:pubmed
pubmed-article:15505054pubmed:issnTypePrintlld:pubmed
pubmed-article:15505054pubmed:volume45lld:pubmed
pubmed-article:15505054pubmed:ownerNLMlld:pubmed
pubmed-article:15505054pubmed:authorsCompleteYlld:pubmed
pubmed-article:15505054pubmed:pagination4041-8lld:pubmed
pubmed-article:15505054pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:meshHeadingpubmed-meshheading:15505054...lld:pubmed
pubmed-article:15505054pubmed:year2004lld:pubmed
pubmed-article:15505054pubmed:articleTitleEffects of topically instilled bunazosin, an alpha1-adrenoceptor antagonist, on constrictions induced by phenylephrine and ET-1 in rabbit retinal arteries.lld:pubmed
pubmed-article:15505054pubmed:affiliationResearch and Development Division, Santen Pharmaceutical Co. Ltd., Nara, Japan.lld:pubmed
pubmed-article:15505054pubmed:publicationTypeJournal Articlelld:pubmed